Na He

Department of Pharmacy, Peking University Third Hospital, Beijing, China, China (People's Republic)

Poster(s):

• (B-139) A comparative evaluation of potential rivaroxaban drug interactions from four database programs
  Monday, August 25, 2025

  11:30 AM - 1:00 PM ET

• (A-100) Comparative effectiveness of angiotensin-converting enzyme inhibitors and angiotensin II receptor blockers on cardiovascular outcomes in older adults with type 2 diabetes mellitus: a target trial emulation study
  Sunday, August 24, 2025

  12:00 PM - 1:30 PM ET

• (SLC-041) Remdesivir and Renal Outcomes in Hospitalized COVID-19 Patients Without Severe Renal Impairment: A Retrospective Cohort Study
  Tuesday, August 26, 2025

  12:15 PM - 1:15 PM ET